LAUSR

A 17-year-old Palestinian patient has been undergoing peritoneal dialysis for the past 4 years owing to reflux nephropathy. The patient was recently diagnosed positive for coronavirus disease 2019. Seven days after the diagnosis she complained of loss of vision in the right eye. The patient was referred for an angiography test for suspected right eye infarct. Fluorescein sodium was given by intravenous injection to examine the ophthalmic vasculature by retinal angiography. There was an indication of an eye infract. She was discharged and on returning home started her peritoneal dialysis. She began to drain the DIANEAL fluid and noticed a dark green fluid instead of the transparent fluid that comes out in every dialysis. After much inquiry the nephrologist decided to perform 6 short cycles of 1 hour each lasting for 7 hours altogether. The shade of the fluid began to change but the change was insufficient. The nephrologist decided to continue with the procedure. It was only on the sixth day that the color reverted to the familiar transparent shade. Over 6 days, the patient felt good, had no further complaints, except for the original complaint of loss of vision in the right eye. Her anxiety, however, was rising owing to the lack of familiarity with the DIANEL green fluid in her body draining. As for the nephrologist, it was only on the third day, when the fluid began to clear, that he could relax.